2Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in Adult[J]. J Am Coll Cardiol, 2005, 46(6): 1 -82.
3Pitt B, Zannad F, Remme W, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J]. NEnglJMed, 1999, 341:709 -717.
4Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction[J]. N Engl J Med, 2003,348:1309 -1321.
5Jong P, Yusuf S, Rousseau MF,et al. Effect of enalapril on 12year of survival and life expectancy in patients with left ventrieular systolic dysfunction : A follow-up study [ J ]. Lancet, 2003, 361:1843-1848.
62009 Focused Update Incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American Cardiology Foundation/American Heart Association Task Force on Practice guidelines [ J ]. J Am Coil Cardiol, 2009,53: 1 -90.
7Packer M, Coats AJS, Fowler MB, et al. Effect of Carvedilol on Survival in chronic Heart Failure[ J]. N Engl J Med, 2001,344: 1651-1658.
